Company Filing History:

3 out of 62

Boehringer Ingelheim (canada) Ltd.

patents

2 out of 18

Bio-mega/boehringer Ingelheim Research Inc.

Years Active: 1995-1998

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5846941 - Isosteric antiherpes peptide derivatives II (1998-12-08),

2. 5830864 - Antiherpes peptide derivatives having a ureido n-terminus (1998-11-03),

3. 5700780 - Antiviral peptide derivatives having a 2-oxoalkyl amino acid side chain (1997-12-23),

4. 5484771 - Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus (1996-01-16),

5. 5476841 - Inhibitors of herpes viral ribonucleotide reductase (1995-12-19),

6. 5380727 - Synergistic combination for treating herpes infections (1995-01-10),

Title: The Inventor Profile of Robert Deziel

Introduction: Robert Deziel is a renowned inventor based in Ville Mont-Royal, Canada, known for his groundbreaking contributions to various industries.

Latest Patents: Robert Deziel holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Robert Deziel has established himself as a leading figure in the Canadian innovation scene, with a track record of turning creative concepts into successful inventions.

Collaborations: Throughout his career, Robert Deziel has collaborated with top research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Robert Deziel's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the landscape of Canadian innovation for years to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

5 patents (CIPO):

Please report any incorrect information to support@idiyas.com